Mg OSTEOREVIVE;Mg OSTEOCRETE
Bone Solutions, Inc. · Decision date Sep 11, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-11 for K262230, submitted 06/30/2026 by Bone Solutions, Inc. of Colleyville, Texas, through correspondent PaxMed International, LLC. The device is listed as Mg OSTEOREVIVE™;Mg OSTEOCRETE™, under regulation 888.3045 in the classification Filler, Bone Void, Calcium Compound, product code MQV with subsequent codes MBP and OIS. The review panel and medical specialty are both orthopedic, and the submission was a traditional 510(k) not reviewed by a third party.
SESE in the 510(k) pathway means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record does not identify which predicate was cited, which component or formulation change was the subject of the submission, or the specific indications, materials and instructions for use, so those details remain unknown from this page. The record also lists no combination product status and no authorized predetermined change control plan.
The page was last updated 11/02/2026 and carries no summary statement text in the supplied data, so any clinical performance or labeling claims would require the underlying FDA documents rather than this listing.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262230
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Bone Solutions, Inc.
- Product code
- MQV
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Filler, Bone Void, Calcium Compound.
- Applicant
- Bone Solutions, Inc.
- Product code
- MQV
- FDA device class
- 2
FDA decision timeline
K262230 received
Application receipt date recorded by FDA.
K262230 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MQV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PearlBone Putty 1600K260496 | Marine Biomedical | 510(k) clearance | Nov 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bone Solutions, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Colleyville, TX
Sources and methodology
- Original FDA record: K262230
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records